Christina Kelsey Zigler

Adjunct Associate Professor in Population Health Sciences

Population Health Sciences

christina.zigler@duke.edu

DUMC Box 104023, Durham, NC 27708

215 Morris Street, Suite 210, Durham, NC 27708

More About This Person

At a Glance

Credentials
1. Education

Academic Experience

Global Scholarship

Keywords

Research
1. Selected Grants
2. External Relationships

Scholarly Works

Teaching & Mentoring
1. Recent Courses

Recognition

Professional Activities

Embed Profile Data

Embed Profile Data

Scholarly Works - Conferences

Cross-sectional quantitative validation of the paediatric Localized Scleroderma Quality of Life Instrument (LoSQI): A disease-specific patient-reported outcome measure.

Conference J Eur Acad Dermatol Venereol · July 2023 BACKGROUND: The Localized Scleroderma Quality of Life Instrument (LoSQI) is a disease-specific patient-reported outcome (PRO) measure designed for children and adolescents with localized scleroderma (LS; morphea). This tool was developed using rigorous PRO ... Full text Link to item Cite

International Validation of the Total Morbidity Score for Juvenile Localized Scleroderma: 2023 Update

Conference ARTHRITIS & RHEUMATOLOGY · April 2023 Link to item Cite

What Happens After Juvenile Myositis Patients Screen Positive for Mental Health Comorbidities? Update from a Multicenter Juvenile Myositis Mental Health Screening Pilot Study

Conference ARTHRITIS & RHEUMATOLOGY · April 2023 Link to item Cite

Communication ability in individuals with Angelman syndrome and Rett syndrome: a comparative study

Conference QUALITY OF LIFE RESEARCH · November 2022 Link to item Cite

Understanding Reliability of the Observer-Reported Communication Ability (ORCA) Measure from the Perspective of Generalizability Theory

Conference QUALITY OF LIFE RESEARCH · November 2022 Link to item Cite

How Much Is Enough?: Recommendations for Minimum Sample Sizes for Common Psychometric Analyses

Conference QUALITY OF LIFE RESEARCH · November 2022 Link to item Cite

Validation of a patient-reported outcome measure in adults with morphea

Conference JOURNAL OF INVESTIGATIVE DERMATOLOGY · August 2022 Link to item Cite

Global impressions of change for instrument validation: Adult problems in pediatric samples

Conference QUALITY OF LIFE RESEARCH · October 2021 Link to item Cite

The Observer-Reported Communication Ability (ORCA) measure: Validation for use in clinical trials for individuals with Angelman syndrome

Conference QUALITY OF LIFE RESEARCH · October 2020 Link to item Cite

Regulatory development of a novel outcome measure to assess communication ability in children with Angelman syndrome

Conference QUALITY OF LIFE RESEARCH · October 2020 Link to item Cite

Designing measures of communication ability in individuals with Angelman syndrome

Conference QUALITY OF LIFE RESEARCH · October 1, 2019 Link to item Cite

A novel IRTree Model for identifying extreme response styles using anchoring vignettes

Conference QUALITY OF LIFE RESEARCH · October 2019 Link to item Cite

LATENT CLASS TRAJECTORY ANALYSIS OF CSF BRAIN-DERIVED NEUROTROPHIC FACTOR METHYLATION FOLLOWING SUBARACHNOID HEMORRHAGE IN ADULTS

Conference JOURNAL OF NEUROTRAUMA · July 1, 2019 Link to item Cite

Analyze Myositis with Ultrasound and Exercise (AMUSE) Kids- Initial Analysis of Longitudinal Data

Conference ARTHRITIS & RHEUMATOLOGY · September 2018 Link to item Cite

Stepping It up: The Use of Physical Activity Monitors As an Outcome Measure in Juvenile Myositis

Conference ARTHRITIS & RHEUMATOLOGY · September 2018 Link to item Cite

The Localized Scleroderma Quality of Life Instrument (LoSQI): Initial Validation in Pediatric Localized Scleroderma

Conference ARTHRITIS & RHEUMATOLOGY · October 1, 2017 Link to item Cite

Establishing Quality of Life Content Domains in Pediatric Localized Scleroderma

Conference ARTHRITIS & RHEUMATOLOGY · October 1, 2016 Link to item Cite

Patient and Parent Global Assessments of Disease Impact in Pediatric Localized Scleroderma: Correlates of Patient Reported Health-Related Quality of Life and Parent Reported Family Impact Domains

Conference ARTHRITIS & RHEUMATOLOGY · October 2016 Link to item Cite

Prospective, Standardized, Longitudinal Assessment Reveals Higher Prevalence of Extracutaneous Manifestations in a Pediatric Localized Scleroderma Cohort

Conference ARTHRITIS & RHEUMATOLOGY · October 1, 2015 Link to item Cite

Predictors of Longitudinal Quality of Life Impact in Pediatric Localized Scleroderma

Conference ARTHRITIS & RHEUMATOLOGY · October 1, 2015 Link to item Cite

Tumor Necrosis Factor-a (TNF-a) and Interferon Gamma Inducible Protein-10 (IP-10) As Predictors of Active Disease Status in Localized Scleroderma

Conference ARTHRITIS & RHEUMATOLOGY · October 2015 Link to item Cite

Circulating T-Helper Cell-Associated Cytokines and Chemokines in Localized Scleroderma.

Conference ARTHRITIS & RHEUMATOLOGY · October 2014 Link to item Cite

Predictors of Disease Relapse in Juvenile Localized Scleroderma

Conference ARTHRITIS & RHEUMATOLOGY · October 2014 Link to item Cite

Relationships Between Physician and Patient Scored Clinical Outcome Measures In Pediatric Localized Scleroderma

Conference ARTHRITIS AND RHEUMATISM · October 1, 2013 Link to item Cite

A Pilot Study Of Juvenile Localized Scleroderma (jLS) Consensus Treatment Plans

Conference ARTHRITIS AND RHEUMATISM · October 2013 Link to item Cite

Children's Hospital of Pittsburgh Pediatric Onset En Coup De Sabre and Parry-Romberg Syndrome Cohort

Conference ARTHRITIS AND RHEUMATISM · October 2012 Link to item Cite

Reliability of Scoring a Disease Damage Measure for Juvenile Localized Scleroderma

Conference ARTHRITIS AND RHEUMATISM · October 2012 Link to item Cite

Initial Evaluation of a Localized Scleroderma (LS) Clinical Activity Measure.

Conference ARTHRITIS AND RHEUMATISM · October 2012 Link to item Cite

Gamma Interferon-Induced Protein-10 (IP-10) As a Potential Biomarker for Disease Activity in Pediatric Localized Scleroderma

Conference ARTHRITIS AND RHEUMATISM · October 2012 Link to item Cite

Increasing Serum IL-17F Levels in Pediatric Localized Scleroderma As Disease Enters Remission.

Conference ARTHRITIS AND RHEUMATISM · October 2011 Link to item Cite

Circulating IP-10 and MCP-1 Levels in Active Localized Scleroderma.

Conference ARTHRITIS AND RHEUMATISM · October 2011 Link to item Cite